Evidence map›Paper›PMID 41823120›Full record

ArticleJournal of the American Chemical Society2026

Unlocking the Silent Proteome: Chemoselective Asn/Gln Activation for Multidimensional Protein Diversification.

Benjamin Emenike, Zachary E Paikin, John M Talbott, Anna Lidskog, Bao Quang Gia Le, Jagannath Swaminathan, Eric V Anslyn, Monika Raj

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Benjamin EmenikeDepartment of Chemistry, Emory University, Atlanta, Georgia 30322, United States.ORCID 0009-0006-0367-2234
Zachary E PaikinDepartment of Chemistry, Emory University, Atlanta, Georgia 30322, United States.ORCID 0009-0000-6480-9106
John M TalbottDepartment of Chemistry, Emory University, Atlanta, Georgia 30322, United States.ORCID 0000-0002-1579-1285
Anna LidskogDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, United States.ORCID 0000-0001-6731-7684
Bao Quang Gia LeDepartment of Chemistry, Emory University, Atlanta, Georgia 30322, United States.
Jagannath SwaminathanDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, United States.
Eric V AnslynDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, United States.ORCID 0000-0002-5137-8797
Monika RajDepartment of Chemistry, Emory University, Atlanta, Georgia 30322, United States.ORCID 0000-0001-9636-2222

Funding

Chemistry for next-generation single-molecule fluorosequencing technology 2.0.R01HG012941 · NHGRI · EMORY UNIVERSITY · PI RAJ, MONIKA · 2023 to 2023
$2.1M
Facilitating the Chemistry of FluorosequencingR35GM149308 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Eric V. Anslyn · 2023 to 2026
$1.5M
NHGRI NIH HHS R01 HG012941NIGMS NIH HHS R35 GM149308
6 · The paper itself

Abstract

Amides are ubiquitous in pharmaceuticals, natural products, and biomolecules, owing to their exceptional stability and hydrogen-bonding capacity. Among the amino acids, asparagine (Asn) and glutamine (Gln) contain neutral primary amide side chains and constitute over 8% of the human proteome. Despite their abundance, these residues have remained largely inaccessible to selective chemical modification due to their low intrinsic reactivity and the propensity of proteinogenic side chains to poison transition-metal catalysts via chelation. Here, we report a general strategy that converts the primary amides of Asn and Gln into bioorthogonal nitrile handles, which can be further diversified through carbometalation with aryl boronic acids to yield aryl ketone products. This transformation proceeds with exceptional chemoselectivity, enabling the modification of native peptides and proteins. We demonstrate its broad utility in the synthesis of unnatural amino acids, late-stage diversification of peptides, fluorosequencing of Asn residues, and site-selective protein modification, culminating in the synthesis of a functional antibody-fluorophore conjugate. The versatility and selectivity of this approach expand the accessible chemical space of biomolecules and provide a powerful route for uncovering previously uncharacterized Asn/Gln sites within the chemically silent proteome.

Indexed as

AsparagineGlutamineProteomeHumansAsparagineGlutamineProteome

Identifiers

PMID41823120
PMCPMC13022855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.